Characterisation of novel subtypes in B progenitor acute lymphoblastic leukaemia
Dr Zhaohui Gu - St. Jude Children's Research Hospital, Memphis, USA
Characterisation of novel subtypes in B progenitor acute lymphoblastic leukaemia ( Dr Zhaohui Gu - St. Jude Children's Research Hospital, Memphis, USA )
19 Dec 2018
Bispecific CD19/22 CAR therapy in children and young adults with ALL
Dr Liora M Schultz - Stanford University, Palo Alto, USA
Bispecific CD19/22 CAR therapy in children and young adults with ALL ( Dr Liora M Schultz - Stanford University, Palo Alto, USA )
17 Dec 2018
Matched targeted therapy for paediatric patients with relapsed, refractory or hi...
Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA
Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias ( Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA )
6 Dec 2018
Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for ...
Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for children with acute leukaemia ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )
6 Dec 2018
Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor ...
Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor relapsed/refractory ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )
6 Dec 2018
ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline t...
Dr Lorenz Trümper - Georg August University, Göttingen, Germany
ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas ( Dr Lorenz Trümper - Georg August University, Göttingen, Germany )
6 Dec 2018
Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients
Dr Stephan Grupp - Children's Hospital of Philadelphia, Philadelphia, USA
Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients ( Dr Stephan Grupp - Children's Hospital of Philadelphia, Philadelphia, USA )
2 Dec 2018
The benefits of a stem cell transplant after CAR T-cell therapy in paediatric pa...
Dr Corinne Summers - Seattle Children's Hospital, Seattle, USA
The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients ( Dr Corinne Summers - Seattle Children's Hospital, Seattle, USA )
2 Dec 2018
Inhibiting the immune system’s natural response may boost benefits and sustainab...
Dr Shannon Maude - Children’s Hospital of Philadelphia, Philadelphia, USA
Inhibiting the immune system’s natural response may boost benefits and sustainability of CAR T therapy ( Dr Shannon Maude - Children’s Hospital of Philadelphia, Philadelphia, USA )
1 Dec 2018
Latest analysis of the ELIANA trial for acute lymphocytic leukaemia
Dr Stephan Grupp - University of Pennsylvania, Philadelphia, USA
Latest analysis of the ELIANA trial for acute lymphocytic leukaemia ( Dr Stephan Grupp - University of Pennsylvania, Philadelphia, USA )
1 Dec 2018
Four cycles of chemotherapy as effective as six for diffuse large B-Cell lymphom...
Dr Viola Pöschel - Saarland University Medical School, Homburg, Germany
Four cycles of chemotherapy as effective as six for diffuse large B-Cell lymphoma ( Dr Viola Pöschel - Saarland University Medical School, Homburg, Germany )
1 Dec 2018
Latest advances in acute lymphoblastic leukaemia and paediatrics in HARMONY
Prof Anthony Moorman - Newcastle University, UK, HARMONY Partner
Latest advances in acute lymphoblastic leukaemia and paediatrics in HARMONY ( Prof Anthony Moorman - Newcastle University, UK, HARMONY Partner )
26 Nov 2018